NeuroMetrix Inc (NURO)
4.395
+0.02
(+0.57%)
USD |
NASDAQ |
May 01, 16:00
4.42
+0.02
(+0.57%)
After-Hours: 20:00
NeuroMetrix Free Cash Flow: -6.268M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -6.268M |
September 30, 2023 | -6.256M |
June 30, 2023 | -6.293M |
March 31, 2023 | -5.688M |
December 31, 2022 | -5.313M |
September 30, 2022 | -4.349M |
June 30, 2022 | -3.146M |
March 31, 2022 | -2.896M |
December 31, 2021 | -2.205M |
September 30, 2021 | -1.405M |
June 30, 2021 | -0.8766M |
March 31, 2021 | -1.359M |
December 31, 2020 | -2.067M |
September 30, 2020 | -2.416M |
June 30, 2020 | -3.682M |
March 31, 2020 | -4.853M |
December 31, 2019 | -3.669M |
September 30, 2019 | -4.361M |
June 30, 2019 | -2.177M |
March 31, 2019 | 1.084M |
December 31, 2018 | 2.718M |
September 30, 2018 | 0.2119M |
June 30, 2018 | -3.101M |
March 31, 2018 | -7.407M |
December 31, 2017 | -12.82M |
Date | Value |
---|---|
September 30, 2017 | -13.19M |
June 30, 2017 | -13.98M |
March 31, 2017 | -14.89M |
December 31, 2016 | -15.18M |
September 30, 2016 | -15.02M |
June 30, 2016 | -14.85M |
March 31, 2016 | -14.52M |
December 31, 2015 | -13.69M |
September 30, 2015 | -12.69M |
June 30, 2015 | -11.14M |
March 31, 2015 | -9.112M |
December 31, 2014 | -7.906M |
September 30, 2014 | -6.710M |
June 30, 2014 | -6.424M |
March 31, 2014 | -6.445M |
December 31, 2013 | -6.641M |
September 30, 2013 | -7.591M |
June 30, 2013 | -8.306M |
March 31, 2013 | -8.481M |
December 31, 2012 | -9.283M |
September 30, 2012 | -8.488M |
June 30, 2012 | -7.998M |
March 31, 2012 | -7.621M |
December 31, 2011 | -6.889M |
September 30, 2011 | -7.421M |
Free Cash Flow Range, Past 5 Years
-6.293M
Minimum
Jun 2023
-0.8766M
Maximum
Jun 2021
-3.646M
Average
-3.669M
Median
Dec 2019
Free Cash Flow Benchmarks
Teleflex Inc | 419.20M |
Perspective Therapeutics Inc | -37.98M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Catheter Precision Inc | -20.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.450M |
Cash from Investing (Quarterly) | 0.098M |
Cash from Financing (Quarterly) | 1.624M |
Free Cash Flow Per Share (Quarterly) | -1.295 |
Free Cash Flow to Equity (Quarterly) | -1.496M |
Free Cash Flow Yield | -136.1% |